Atea Pharmaceuticals
AVIR
AVIR
105 hedge funds and large institutions have $189M invested in Atea Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
1.9% less ownership
Funds ownership: 68.59% → 66.69% (-1.9%)
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
55% less call options, than puts
Call options by funds: $115K | Put options by funds: $255K
Holders
105
Holding in Top 10
1
Calls
$115K
Puts
$255K
Top Buyers
| 1 | +$3.21M | |
| 2 | +$1.05M | |
| 3 | +$670K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$616K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$609K |
Top Sellers
| 1 | -$7.04M | |
| 2 | -$2.12M | |
| 3 | -$1.26M | |
| 4 |
AI
Acuitas Investments
Seattle,
Washington
|
-$1.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$647K |